Pharma Industry News

Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’

Sanofi is currently collaborating with Translate Bio on a mRNA-based COVID-19 vaccine candidateOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]